Congress Asset Management CO Amgen Inc Transaction History

Congress Asset Management CO

$14.3 Billion
Q3 2024

A detailed history of Congress Asset Management CO transactions in Amgen Inc stock. As of the latest transaction made, Congress Asset Management CO holds 53,541 shares of AMGN stock, worth $15.5 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

53,541

Previous 53,968 0.79%

Holding current value

$15.5 Million

Previous $16.9 Million 2.31%

% of portfolio

0.12%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $132,105 - $144,061	-427 Reduced 0.79%	53,541 $17.3 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $32,843 - $39,913	-125 Reduced 0.23%	53,968 $16.9 Million
Q1 2024 Apr 11, 2024	SELL	$268.87 - $324.56 $589,094 - $711,110	-2,191 Reduced 3.89%	54,093 $15.4 Million
Q4 2023 Mar 04, 2024	SELL	$255.7 - $288.46 $549,499 - $619,900	-2,149 Reduced 3.68%	56,284 $16.2 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $297,364 - $369,185	1,360 Added 2.38%	58,433 $15.7 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $45,425 - $53,714	-212 Reduced 0.37%	57,073 $12.7 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $222,177 - $270,796	984 Added 1.75%	57,285 $13.8 Million
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $196,736 - $249,977	859 Added 1.55%	56,301 $0
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $295,838 - $333,651	1,318 Added 2.44%	55,442 $12.5 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $151,115 - $168,164	655 Added 1.23%	54,124 $13.2 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $777,312 - $859,910	3,545 Added 7.1%	53,469 $12.9 Million
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $57,476 - $65,776	-289 Reduced 0.58%	49,924 $11.2 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $137,763 - $161,406	649 Added 1.31%	50,213 $10.7 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $362,516 - $402,185	1,552 Added 3.23%	49,564 $12.1 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $352,171 - $410,398	1,587 Added 3.42%	48,012 $11.9 Million
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $513,469 - $611,450	2,373 Added 5.39%	46,425 $10.7 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $13,140 - $14,613	-56 Reduced 0.13%	44,052 $11.2 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $277,131 - $340,078	-1,401 Reduced 3.08%	44,108 $10.4 Million
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $120,096 - $159,280	659 Added 1.47%	45,509 $9.23 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $181,452 - $233,228	959 Added 2.18%	44,850 $10.8 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $200,922 - $240,747	1,154 Added 2.7%	43,891 $8.49 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $268,720 - $315,000	1,612 Added 3.92%	42,737 $7.88 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $90,073 - $101,532	498 Added 1.23%	41,125 $7.81 Million
Q4 2018 Jan 25, 2019	BUY	$178.4 - $208.25 $55,482 - $64,765	311 Added 0.77%	40,627 $7.91 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $68,372 - $77,080	369 Added 0.92%	40,316 $8.36 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $148,448 - $166,739	894 Added 2.29%	39,947 $7.37 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $252,450 - $295,020	1,490 Added 3.97%	39,053 $6.66 Million
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $234,449 - $261,951	1,389 Added 3.84%	37,563 $6.53 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $6.05 Million - $6.91 Million	36,174	36,174 $6.75 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Amgen Inc Transaction History